COVENANT HEALTH HOBBS HOSPITAL
1. Target Overview & Investment Thesis
COVENANT HEALTH HOBBS HOSPITAL is a 34-bed under-performing / distressed in LEA, NM with $31.8M in net patient revenue and a -57.7% operating margin. The hospital serves a payer mix of 26.8% Medicare, 1.0% Medicaid, and 72.1% commercial.
Thesis: Turnaround. Our ML models identify $2.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -57.7% to -50.3% (+736bps).
| Net Revenue HCRIS | $31.8M |
| Current EBITDA COMPUTED | $-18.3M |
| Operating Margin COMPUTED | -57.7% |
| Occupancy HCRIS | 26.6% |
| Revenue / Bed COMPUTED | $935K |
| Net-to-Gross HCRIS | 19.1% |
| Distress Probability ML | 51.7% |
2. Market Context & Competitive Position
NM has 55 Medicare-certified hospitals with a median operating margin of -2.7%. The target's margin of -57.7% places it below the state median. Among 31 size-comparable peers (17-68 beds), the median margin is -1.7%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (17-68), prioritizing same-state peers. 31 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| COVENANT HEALTH HOBBS HOSPITAL (Target) | NM | 34 | $31.8M | -57.7% |
| GERALD CHAMPION REGIONAL MEDIC | NM | 66 | $245.9M | -11.6% |
| NOR-LEA HOSPITAL | NM | 25 | $131.5M | 0.9% |
| UNM SANDOVAL REGIONAL MEDICAL | NM | 60 | $104.5M | -11.9% |
| CARLSBAD MEDICAL CENTER | NM | 53 | $97.1M | 19.9% |
| SANTA FE MEDICAL CENTER | NM | 36 | $95.0M | -26.5% |
| GILA REGIONAL MEDICAL CENTER | NM | 25 | $83.6M | -3.6% |
| HOLY CROSS HOSPITAL | NM | 25 | $72.9M | -20.0% |
| LINCOLN COUNTY MEDICAL CENTER | NM | 25 | $66.7M | 4.1% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.3M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $668K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $636K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $630K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $387K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $20K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-18.3M |
| + RCM Uplift | +$2.3M |
| Pro Forma EBITDA | $-16.0M |
| Current Margin | -57.7% |
| Pro Forma Margin | -50.3% |
| WC Released (1x) | $1.2M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-28.2M | $-97.6M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-28.2M | $-116.5M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-25.4M | $-117.9M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-25.4M | $-136.1M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-31.0M | $-100.1M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-31.0M | $-120.2M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Low occupancy | At 26.6%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 51.7% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 31 hospitals with 17-68 beds
- Same-state prioritization (n=32)
- Comp margins: P25=-20.3% / P50=-1.7% / P75=8.6%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 27, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.